Importantly, in certain cancer types, inhibition of the PI3K/Akt pathway has been shown to induce compensatory activation of the MAPK/ERK pathway, thereby sustaining cell survival despite inhibition of PI3K [54]. The gene discussed is AKT1; the disease is cancer.